These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3020469

  • 1. Low affinity inhibition of opioid receptor binding by FMRFamide.
    Zhu XZ, Raffa RB.
    Neuropeptides; 1986 Jul; 8(1):55-61. PubMed ID: 3020469
    [Abstract] [Full Text] [Related]

  • 2. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
    Raffa RB, Kim A, Rice KC, de Costa BR, Codd EE, Rothman RB.
    Peptides; 1994 Jul; 15(3):401-4. PubMed ID: 7937312
    [Abstract] [Full Text] [Related]

  • 3. FMRFamide: an endogenous peptide with marked inhibitory effects on opioid-induced feeding behavior.
    Kavaliers M, Hirst M.
    Brain Res Bull; 1986 Sep; 17(3):403-8. PubMed ID: 3533222
    [Abstract] [Full Text] [Related]

  • 4. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
    Raffa RB.
    NIDA Res Monogr; 1990 Sep; 105():243-9. PubMed ID: 1678861
    [Abstract] [Full Text] [Related]

  • 5. The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals.
    Raffa RB.
    Peptides; 1988 Sep; 9(4):915-22. PubMed ID: 3067224
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to opioid receptors in frog brain membrane preparations.
    Wollemann M, Farkas J, Tóth G, Benyhe S.
    J Neurochem; 1994 Oct; 63(4):1460-5. PubMed ID: 7931298
    [Abstract] [Full Text] [Related]

  • 7. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M, Sagan S, Mor A, Pelaprat D, Rostene W, Delfour A, Nicolas P.
    Eur J Biochem; 1990 May 20; 189(3):625-35. PubMed ID: 2161761
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M, Magnan J.
    Mol Pharmacol; 1990 May 20; 37(5):694-703. PubMed ID: 2160061
    [Abstract] [Full Text] [Related]

  • 9. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P, Roques BP, Zajac JM.
    Life Sci; 1987 Aug 10; 41(6):723-31. PubMed ID: 3039270
    [Abstract] [Full Text] [Related]

  • 10. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL, Recht LD, Pasternak GW.
    Mol Pharmacol; 1984 Jan 10; 25(1):29-37. PubMed ID: 6323950
    [Abstract] [Full Text] [Related]

  • 11. Opiate receptor binding profile in the rabbit cerebellum and brain membranes.
    Ho CL, Hammonds RG, Li CH.
    Biochem Pharmacol; 1985 Apr 01; 34(7):925-31. PubMed ID: 2985086
    [Abstract] [Full Text] [Related]

  • 12. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor.
    Benyhe S, Hepp J, Simon J, Borsodi A, Medzihradszky K, Wollemann M.
    Neuropeptides; 1987 Apr 01; 9(3):225-35. PubMed ID: 3037428
    [Abstract] [Full Text] [Related]

  • 13. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH, Maurset AR, Holmen AT, Enger M.
    Acta Pharmacol Toxicol (Copenh); 1984 Mar 01; 54(3):195-200. PubMed ID: 6144235
    [Abstract] [Full Text] [Related]

  • 14. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB, Schmidt WK, Kuhar MJ.
    J Pharmacol Exp Ther; 1988 Jan 01; 244(1):391-402. PubMed ID: 2826773
    [Abstract] [Full Text] [Related]

  • 15. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF, Goldstein A.
    Mol Pharmacol; 1984 May 01; 25(3):337-42. PubMed ID: 6328259
    [Abstract] [Full Text] [Related]

  • 16. Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain.
    Ori C, Ford-Rice F, London ED.
    Anesthesiology; 1989 Mar 01; 70(3):541-4. PubMed ID: 2564264
    [Abstract] [Full Text] [Related]

  • 17. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M, Sagan S, Mor A, Delfour A, Nicolas P.
    Mol Pharmacol; 1989 Jun 01; 35(6):774-9. PubMed ID: 2543911
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin-releasing hormone (GnRF), molluscan cardioexcitatory peptide (FMRFamide), enkephalin and related neuropeptides affect goldfish retinal ganglion cell activity.
    Walker SE, Stell WK.
    Brain Res; 1986 Oct 08; 384(2):262-73. PubMed ID: 3535991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
    Ensinger HA.
    Eur J Pharmacol; 1983 Apr 22; 89(1-2):143-7. PubMed ID: 6305681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.